List of Studies ( Metabolite:Glucoheptonic acid)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
|---|---|---|---|---|---|---|---|
| ST002234 | AN003644 | A metabolic map of the DNA damage response identifies PRDX1 in nuclear ROS scavenging and aspartate synthesis | Cultured cells | Human | DNA damage response | CRG | au |
| ST000084 | AN000136 | Model-driven multi-omic data analysis elucidates metabolic immunomodulators of macrophage activation | Macrophages | Mouse | Pacific Northwest National Laboratory | Peak area | |
| ST000092 | AN000146 | A statistical analysis of the effects of urease pre-treatment on the measurement of the urinary metabolome by gas chromatography?mass spectrometry | Urine | Human | Pacific Northwest National Laboratory | Peak area | |
| ST000918 | AN001503 | GC/MS metabolomic plasma analysis | Blood | Human | Cancer | Universidad de los Andes, Colombia | Peak area |
| ST001117 | AN001813 | A Metabolomic study of hibernating Syrian hamster brain: in search of neuroprotective agents | Brain | Hamster | Universidad CEU San Pablo | Peak area | |
| ST001937 | AN003150 | Comprehensive plasma metabolomics and lipidomics based management of benign and malignant solitary pulmonary nodules | Blood | Human | Cancer | China Pharmaceutical University | peak height |
| ST000421 | AN000664 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
| ST000421 | AN000666 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
| ST000422 | AN000667 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
| ST000422 | AN000668 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
| ST000422 | AN000670 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
| ST000551 | AN000841 | Investigating large scale metabolomics in mice tissue lacking insulin receptors and IGF-1 receptors | Muscle | Mouse | Diabetes | Mayo Clinic | Peak intensity |
| ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
| ST002094 | AN003422 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
| ST000046 | AN000076 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
| ST000046 | AN000077 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
| ST000046 | AN000078 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
| ST000046 | AN000079 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
| ST000047 | AN000082 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
